News & Views

• Occam Places Jeff Landau as CBO and Chau Cheng as VP IR at CytomX Therapeutics
  June 8, 2021
• Occam Places Paul Audhya as CMO at KalVista Pharmaceuticals
  May 3, 2021
• Occam Places Vatnak Vat-Ho as CBO at Ryvu Therapeutics
  April 28, 2021
• Occam Places Teresa McRoberts as CFO at Triumvira Immunologics
  April 27, 2021
• Occam Places David Bredt as Executive Partner at MPM Capital
  April 9, 2021
• Occam Places Ann Taylor, CMO of AstraZeneca, on Board of Unlearn.AI
  March 10, 2021
• Occam Places Wildon Farwell as CMO at Dyne Therapeutics
  March 4, 2021
• Occam Places Louisa Daniels as General Counsel at Recursion
  February 18, 2021
• Occam Places Tim Trost as CFO at Werewolf Therapeutics
  February 13, 2021
• Occam Places Brian Goldman as SVP and Chief Computation Officer at ZebiAI
  February 9, 2021
• Occam Places Annette Matthies as CBO at Elicio
  February 2, 2021
• Occam Places Ramona Doyle as CMO at Recursion
  January 13, 2021
• Occam Places Andrew Hall as CBO at IMV
  November 13, 2020
• The Importance of CEO Leadership
  November 3, 2020
• Occam Client and Alvin Shih Led Disarm Therapeutics to be Acquired By Eli Lilly
  October 15, 2020
• Occam Client and Ted Ashburn Led Oncorus Launches IPO
  October 7, 2020
• Emly Conley secures $50M in financing to advance Federation Bio’s microbial platform
  October 6, 2020
• Occam Places Ali Fattaey as CEO of Metabomed
  September 11, 2020
• Occam Places Vijay Reddy as Chief Research & Development Officer of Tmunity Therapeutics
  September 9, 2020
• Occam Places Christopher Silber as Chief Medical Officer of Nocion Therapeutics
  September 1, 2020
• Occam Places Ellen Lubman as Chief Business Officer of Werewolf Therapeutics
  August 13, 2020
• Occam Places Michael Bailey on the Board of IMV Inc.
  July 22, 2020
• Occam Places Emily Conley as CEO of Federation Bio
  July 20, 2020
• BlackRock Leads $50 Million Round in Hydropanel Startup Zero Mass Water
  June 17, 2020
• Occam Remains Alive and Well in the Time of COVID
  June 10, 2020
• Occam Places Matthew Gall as CFO of iTeos Therapeutics
  
• Occam client Accent Therapeutics forms cancer therapeutics collaboration with AstraZeneca
  June 4, 2020
• Variant Bio Aims to Make Use of Humanity’s Genetic Outliers
  May 28, 2020
• Generation Bio tees up $125M IPO to push next-gen gene therapies
  May 26, 2020
• Occam Places Terry-Ann Burrell on the Board of Recursion Pharmaceuticals
  May 5, 2020
• Occam Places Don Manning as CMO of Pacira Biosciences
  May 1, 2020
• Occam Places Gates Foundation Leader as CEO at Variant Bio
  April 6, 2020
• Occam Places Carlos Campoy as SVP & CFO at CytomX
  March 27, 2020
• Occam Places CEO at Ivenix, an F-Prime/WuXi Backed Medical Device Company
  January 20, 2020